June 26, 2014

Orexo AB et al v. Actavis Elizabeth LLC

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. November 22, 2016

    Actavis Infringed Orexo's Zubsolv Patent, Del. Judge Rules

    A Delaware federal judge has ruled that drugmaker Actavis Elizabeth LLC infringed an Orexo AB patent with its planned generic version of opioid addiction treatment Zubsolv, a ruling Orexo said will keep Actavis from commercializing its product until 2019.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS